Literature DB >> 34177303

Alternative Treatment Method for Novel Coronavirus Disease 2019: Coupled Plasma Filtration Adsorption.

Bahadir Ciftci1, Cem Erdogan1, Deniz Kizilaslan1, Mursel Ekinci1, Oktay Olmuscelik2, Yunus Oktay Atalay1.   

Abstract

Entities:  

Year:  2021        PMID： 34177303      PMCID： PMC8184044          DOI： 10.5152/eurasianjmed.2021.20151

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN： 1308-8734


× No keyword cloud information.
  5 in total

1.  Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: A randomized crossover double-blind study.

Authors:  Marcus E Broman; Fredrik Hansson; Jean-Louis Vincent; Mikael Bodelsson
Journal:  PLoS One       Date:  2019-08-01       Impact factor: 3.240

2.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

3.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

4.  A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19.

Authors:  Philip Keith; Matthew Day; Linda Perkins; Lou Moyer; Kristi Hewitt; Adam Wells
Journal:  Crit Care       Date:  2020-04-02       Impact factor: 9.097

Review 5.  The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.

Authors:  Qing Ye; Bili Wang; Jianhua Mao
Journal:  J Infect       Date:  2020-04-10       Impact factor: 38.637
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.